Pituitrin induced hyponatremia clinical analysis.doc

 PAGE \* MERGEFORMAT 11 Pituitrin induced hyponatremia clinical analysis [Abstract] Objective: To summarize the clinical use of vasopressin and related induced hyponatremia. Methods: tuberculosis, bronchiectasis, lung cancer, pulmonary infection with hemoptysis and pituitrin were 132 cases, of which 46 were of low hypernatremia, to limit total daily intake (including oral rehydration volume and volume) or disable pituitrin, the dynamic detection of serum sodium concentration. Results: 46 cases 28 cases of hyponatremia in patients with no clinical symptoms, serum sodium was 126.4 + -3.2 mmol / L; 18 patients had clinical symptoms, serum sodium 110.6 + -6.4 mmol / L, of which nausea and vomiting in 14 cases, 10 cases of muscle weakness, muscle spasm in 8 cases, 7 cases of lethargy, mental disorder in 5 cases, 4 cases of convulsions, coma in 4 cases, 1 case of secondary coma, headache, blindness in 1 case; normal after treatment in 1 ~ 2 d serum sodium to normal, the symptoms disappeared, no 1 patient died, and no sequelae . Conclusion: The use of pituitrin hemoptysis, pay attention to the occurrence of hyponatremia should be dynamic monitoring of serum sodium concentration; the beginning of treatment that should make the appropriate limits on sodium and water, avoid the sodium level is too low to make up sharply after sodium, or can lead to osmotic demyelination disease, manifested as irreversible mental disorders. [Keywords:] hemoptysis; pituitrin; hyponatremia Vasopressin as a medical clamp, in the treatment of bleeding disorders, particularly when hemoptysis is widely used. But in the clinical application process, often lead to hyponatremia. In order to minimize the incidence of hyponatremia This paper is the use of pituitrin in 46 patients with hyponatremia due to the clinical data analysis, are as follows. 1 Materials and Methods 1.1 General information on the use of hospital due to hemoptysis pituitrin 132 patients, are in 2006-2009, Departme